Chapter 8. General Principles of Sensory Processing, Touch, and Pain
Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.
Bruce Bower Marijuana’s medical promise deserves closer, better-funded scientific scrutiny, a new state-of-the-science report concludes. The report, released January 12 by the National Academies of Sciences, Engineering and Medicine in Washington, D.C., calls for expanding research on potential medical applications of cannabis and its products, including marijuana and chemical components called cannabinoids. Big gaps in knowledge remain about health effects of cannabis use, for good or ill. Efforts to study these effects are hampered by federal classification of cannabis as a Schedule 1 drug, meaning it has no accepted medical use and a high potential for abuse. Schedule 1 status makes it difficult for researchers to access cannabis. The new report recommends reclassifying the substance to make it easier to study. Recommendations from the 16-member committee that authored the report come at a time of heightened acceptance of marijuana and related substances. Cannabis is a legal medical treatment in 28 states and the District of Columbia. Recreational pot use is legal in eight of those states and the District. “The legalization and commercialization of cannabis has allowed marketing to get ahead of science,” says Raul Gonzalez, a psychologist at Florida International University in Miami who reviewed the report before publication. While the report highlights possible medical benefits, Gonzalez notes that it also underscores negative consequences of regular cannabis use. These include certain respiratory and psychological problems. |© Society for Science & the Public 2000 - 2017.
Rachel Ehrenberg A protein that sounds the alarm when the body encounters something painful also helps put out the fire. Called Nav1.7, the protein sits on pain-sensing nerves and has long been known for sending a red alert to the brain when the body has a brush with pain. Now, experiments in rodent cells reveal another role for Nav1.7: Its activity triggers the production of pain-relieving molecules. The study, published online January 10 in Science Signaling, suggests a new approach to pain management that takes advantage of this protein’s dual role. “This is very interesting research,” says neuroscientist Munmun Chattopadhyay of Texas Tech University Health Sciences Center El Paso. The findings suggest that when opiates are given for certain kinds of pain relief, also targeting Nav1.7 might lessen the need for those pain relievers, Chattopadhyay says. That could reduce opiate use and their associated side effects. The new research also solves a puzzle that has frustrated researchers and pharmaceutical companies alike. People with rare mutations in the gene for making Nav1.7 feel no pain at all. That discovery, made more than a decade ago, suggested that Nav1.7 was an ideal target for controlling pain. If a drug could block Nav1.7 activity, some kinds of pain might be eradicated (SN: 6/30/12, p 22). Yet drugs designed to do just that didn’t wipe out people’s pain. “It seemed so obvious and simple,” says study leader Tim Hucho, a neuroscientist at the University Hospital Cologne in Germany. “But it was not so simple.” |© Society for Science & the Public 2000 - 2017
Keyword: Pain & Touch
Link ID: 23090 - Posted: 01.12.2017
By Jessica Hamzelou One woman’s unique experiences are helping us understand the nature of synaesthesia. We don’t know yet what causes synaesthesia, which links senses and can enable people to taste words or smell sounds, for example. It may be at least partly genetic, as it tends to run in families. Some researchers think a brain chemical called serotonin might play a role, because hallucinogenic drugs that alter serotonin levels in the brain can create unusual perceptions. There’s also some evidence that synaesthesia can change or disappear, and a detailed assessment of one woman’s experiences is helping Kevin Mitchell at Trinity College Dublin in Ireland and his team investigate. The woman, referred to as “AB”, sees colours when she hears music, linked to pitch, volume or instrument – higher notes have more pastel shades. She also associates colours with people, largely based on personality. Green is linked to loyalty, for instance. But several experiences in her life have caused her synaesthesia to change. “To say she had a series of unfortunate events would be an understatement,” says Mitchell. As a teenager and young adult, AB sustained several concussions, had migraines, contracted viral meningitis and was struck by lightning. © Copyright Reed Business Information Ltd.
Link ID: 23054 - Posted: 01.04.2017
By KEVIN DEUTSCH An anesthetic commonly used for surgery has surpassed heroin to become the deadliest drug on Long Island, killing at least 220 people there in 2016, according to medical examiners’ records. The drug, fentanyl, is a synthetic opioid, which can be 100 times more potent than morphine. The numbers from Long Island are part of a national pattern, as fentanyl fatalities have already surpassed those from heroin in other parts of the country, including New England, as its use has skyrocketed. Part of the reason for the increase is economic — because fentanyl can be manufactured in the lab, it is much cheaper and easier than cultivating heroin. In New York City, more than 1,000 people are expected to die from drug overdoses this year — the first recorded four-digit death total in city history, according to statistics compiled by the Department of Health and Mental Hygiene. Nearly half of all unintentional drug overdose deaths in the city since July have involved fentanyl, the health department said. The medical examiners of Long Island’s two counties, Nassau and Suffolk, compiled the new numbers. “Fentanyl has surpassed heroin as the most commonly detected drug in fatal opioid overdoses,” Dr. Michael J. Caplan, the Suffolk County medical examiner, said in a written statement about the statistics, which were obtained by The New York Times ahead of their release. “The influx of illicitly manufactured fentanyl from overseas is a nationwide issue that requires a multidisciplinary intervention from all levels of government.” Nationwide, recorded deaths from opioids surpassed 30,000 in 2015, according to data compiled by the Centers for Disease Control and Prevention. And overdoses caused by synthetic opioids like fentanyl increased by 72.2 percent in 2015 over 2014 — one of the deadliest year-over-year surges for any drug in United States history, the same data shows. © 2016 The New York Times Company
By Ben Andrew Henry Traveling from the forests and fields of Europe to the grasslands south of the Sahara desert is a monumental trip for anyone, and especially for a diminutive insect. Yet every year, populations of the painted lady (Vanessa cardui) butterfly make that journey over the course of several generations. The logistics of this migratory feat had been speculated for some time, but never fully understood, in part because of the difficulty of tracking the tiny insects across long distances. In a study published October 4 in Biology Letters, researchers reported having measured the isotopic composition of butterfly wings in Europe and south of the Sahara. Since the fraction of heavy hydrogen isotopes in the environment varies geographically, the team used its analysis to identify the origins of butterflies captured, confirming that groups of butterflies in the Sahara did originate in Europe. The butterflies do not linger in Africa long. They most likely make their trip, the authors suggested, to take advantage of the burst of productivity in the tropical savannah that follows the rainy season—and to breed the generation that will start the trip back. Europe’s freshwater eels (Anguilla anguilla) live out their days in rivers and streams, but they never spawn there. Massive catches of larval eels in the Sargasso Sea tipped researchers off a century ago that eels must spawn in the swirling mid-Atlantic gyre of free-floating seaweed and then migrate to Europe. Eels leave their homes in the late fall, but other than that, the details of their journey have been a mystery. © 1986-2016 The Scientist
Keyword: Animal Migration
Link ID: 23029 - Posted: 12.28.2016
by Bethany Brookshire An opioid epidemic is upon us. Prescription painkillers such as fentanyl and morphine can ease terrible pain, but they can also cause addiction and death. The Centers for Disease Control and Prevention estimates that nearly 2 million Americans are abusing or addicted to prescription opiates. Politicians are attempting to stem the tide at state and national levels, with bills to change and monitor how physicians prescribe painkillers and to increase access to addiction treatment programs. Those efforts may make access to painkillers more difficult for some. But pain comes to everyone eventually, and opioids are one of the best ways to make it go away. Morphine is the king of pain treatment. “For hundreds of years people have used morphine,” says Lakshmi Devi, a pharmacologist at the Ichan School of Medicine Mount Sinai in New York City. “It works, it’s a good drug, that’s why we want it. The problem is the bad stuff.” The “bad stuff” includes tolerance — patients have to take higher and higher doses to relieve their pain. Drugs such as morphine depress breathing, an effect that can prove deadly. They also cause constipation, drowsiness and vomiting. But “for certain types of pain, there are no medications that are as effective,” says Bryan Roth, a pharmacologist and physician at the University of North Carolina at Chapel Hill. The trick is constructing a drug with all the benefits of an opioid painkiller, and few to none of the side effects. Here are three ways that scientists are searching for the next big pain buster, and three of the chemicals they’ve turned up. |© Society for Science & the Public 2000 - 2016
Rachel Ehrenberg Scientists investigating what keeps lungs from overinflating can quit holding their breath. Experiments in mice have identified a protein that senses when the lungs are full of air. This protein helps regulate breathing in adult mice and gets breathing going in newborn mice, researchers report online December 21 in Nature. If the protein plays a similar role in people — and a few studies suggest that it does — exploring its activity could help explain disorders such as sleep apnea or chronic obstructive pulmonary disease. “These are extremely well done, very elegant studies,” says neonatologist Shabih Hasan of the University of Calgary in Canada, a specialist in breathing disorders in newborns. Researchers knew that feedback between the lungs and brain maintains normal breathing. But “this research give us an understanding at the cellular level,” says Hasan. “It’s a major advance.” Called Piezo2, the protein forms channels in the membranes of nerve cells in the lungs. When the lungs stretch, the Piezo2 channels detect the distortion caused by the mechanical force of breathing and spring open, triggering the nerves to send a signal. Led by neuroscientist Ardem Patapoutian, researchers discovered that the channels send signals along three different pathways. Mice bred to lack Piezo2 in a cluster of nerve cells that send messages to the spinal cord had trouble breathing and died within 24 hours. Similarly, newborn mice missing Piezo2 channels in nerves that communicate with the brain stem via a structure called the jugular ganglion also died. |© Society for Science & the Public 2000 - 2016.
Keyword: Pain & Touch
Link ID: 23006 - Posted: 12.22.2016
.By JOANNA KLEIN A honey bee gathering pollen on a white flower. Dagmar Sporck/EyeEm, via Getty Images Set your meetings, phone calls and emails aside, at least for the next several minutes. That’s because today you’re a bee. It's time to leave your hive, or your underground burrow, and forage for pollen. Pollen is the stuff that flowers use to reproduce. But it’s also essential grub for you, other bees in your hive and your larvae. Once you’ve gathered pollen to take home, you or another bee will mix it with water and flower nectar that other bees have gathered and stored in the hive. But how do you decide which flowers to approach? What draws you in? In a review published last week in the journal Functional Ecology, researchers asked: What is a flower like from a bee’s perspective, and what does the pollinator experience as it gathers pollen? And that's why we're talking to you in the second person: to help you understand how bees like you, while hunting for pollen, use all of your senses — taste, touch, smell and more — to decide what to pick up and bring home. Maybe you're ready to go find some pollen. But do you even know where to look? © 2016 The New York Times Company
By Melissa Dahl Considering its origin story, it’s not so surprising that hypnosis and serious medical science have often seemed at odds. The man typically credited with creating hypnosis, albeit in a rather primitive form, is Franz Mesmer, a doctor in 18th-century Vienna. (Mesmer, mesmerize. Get it?) Mesmer developed a general theory of disease he called “animal magnetism,” which held that every living thing carries within it an internal magnetic force, in liquid form. Illness arises when this fluid becomes blocked, and can be cured if it can be coaxed to flow again, or so Mesmer’s thinking went. To get that fluid flowing, as science journalist Jo Marchant describes in her recent book, Cure, Mesmer “simply waved his hands to direct it through his patients’ bodies” — the origin of those melodramatic hand motions that stage hypnotists use today.” After developing a substantial following — “mesmerism” became “the height of fashion” in late 1780s Paris, writes Marchant — Mesmer became the subject of what was essentially the world’s first clinical trial. King Louis XVI pulled together a team of the world’s top scientists, including Benjamin Franklin, who tested mesmerism and found its capacity to “cure” was, essentially, a placebo effect. “Not a shred of evidence exists for any fluid,” Franklin wrote. “The practice … is the art of increasing the imagination by degrees.” Maybe so. But that doesn’t mean it doesn’t work. © 2016, New York Media LLC.
Tom Goldman Voters in seven more states said "yes" to marijuana this month. Pot now is legal for recreational or medicinal use in more than half the country. It's still against federal law and classified as a Schedule 1 drug, meaning U.S. officials consider marijuana to have a high risk of abuse or harm, and no accepted medical use in treatment. Also, it's still banned in professional sports. Many athletes hope that will change as momentum grows nationwide for legalization. That's especially true in the National Football League, where pain is a constant companion. Advocates say marijuana could offer a safer and better way to manage the pain. Football hurts. As a fan watching from home, that's not always obvious — players collide, fall down, pop back up. They rarely wince or show weakness. That's just not how it's done in football. Kyle Turley hurt plenty during his eight NFL seasons in the 1990s and 2000s. As an offensive lineman, he was involved in jarring collisions nearly every play when his team had the ball. He hurt after his career -– Turley sometimes walks with a cane. And in a recent video, he displayed one by one the bottles of powerful painkillers he used. "Vicodin, Flexeril, Percocets, Vioxx, morphine," Turley recited as he plopped the bottles down on a kitchen counter. © 2016 npr
By Alice Klein Alzheimer’s disease can be prevented by stopping a crucial brain protein from turning rogue, a study in mice suggests. Tau protein has long been suspected to play a role in causing the condition. In healthy brains, tau is essential for normal cell functioning. But during Alzheimer’s disease, the protein goes haywire, clumping together to form twisted tangles and, it is thought, releasing toxic chemicals that harm the brain. Now Lars Ittner at the University of New South Wales, Australia, and his colleagues have pinpointed a crucial enzyme that controls how tau proteins behave in the brain. The enzyme, called p38γ kinase, helps keep tau in a healthy, tangle-free state, preventing the onset of memory loss and other symptoms in mice that have been bred to develop Alzheimer’s disease. The enzyme seems to block Alzheimer’s by interfering with the action of another problem protein, called beta-amyloid. Like tau, clumps of this protein accumulate in the brains of people with Alzheimer’s, making it another suspected cause of the disease. When beta-amyloid forms these sticky plaques, it can also modify the structure of tau proteins, causing them to form tangles and release toxic chemicals. But Ittner’s team found that p38γ kinase makes a different kind of structural change to tau. If this change is made first, it prevents beta-amyloid from being able to turn tau bad, and mice do not develop the disease. © Copyright Reed Business Information Ltd.
Link ID: 22883 - Posted: 11.18.2016
By CHRIS BUCKLEY BEIJING — When Flappy McFlapperson and Skybomb Bolt sprang into the sky for their annual migration from wetlands near Beijing, nobody was sure where the two cuckoos were going. They and three other cuckoos had been tagged with sensors to follow them from northern China. But to where? “These birds are not known to be great fliers,” said Terry Townshend, a British amateur bird watcher living in the Chinese capital who helped organize the Beijing Cuckoo Project to track the birds. “Migration is incredibly perilous for birds, and many perish on these journeys.” The answer to the mystery — unfolding in passages recorded by satellite for more than five months — has been a humbling revelation even to many experts. The birds’ journeys have so far covered thousands of miles, across a total of a dozen countries and an ocean. The “common cuckoo,” as the species is called, turns out to be capable of exhilarating odysseys. “It’s impossible not to feel an emotional response,” said Chris Hewson, an ecologist with the British Trust for Ornithology in Thetford, England, who has helped run the tracking project. “There’s something special about feeling connected to one small bird flying across the ocean or desert.” But to follow a cuckoo, you must first seduce it. The common cuckoo is by reputation a cynical freeloader. Mothers outsource parenting by laying their eggs in the nests of smaller birds, and the birds live on grubs, caterpillars and similar soft morsels. British and Chinese bird groups decided to study two cuckoo subspecies found near Beijing, because their winter getaways were a puzzle. In an online poll for the project, nearly half the respondents guessed they went somewhere in Southeast Asia. © 2016 The New York Times Company
By Diana Kwon In people who suffer from pain disorders, painful feelings can severely worsen and spread to other regions of the body. Patients who develop chronic pain after surgery, for example, will often feel it coming from the area surrounding the initial injury and even in some parts of the body far from where it originates. New evidence suggests glia, non-neuronal cells in the brain, may be the culprits behind this effect. Glia were once thought to simply be passive, supporting cells for neurons. But scientists now know they are involved in everything from metabolism to neurodegeneration. A growing body of evidence points to their key role in pain. In a study published today in Science, researchers at the Medical University of Vienna report that glia are involved in long-term potentiation (LTP), or the strengthening of synapses, in pain pathways in the spinal cord. Neuroscientists Timothy Bliss and Terje Lømo first described LTP in the hippocampus, a brain area involved in memory, in the 1970s. Since then scientists have been meticulously studying the role this type of synaptic plasticity—the ability of synapses to change in strength—plays in learning and memory. More recently, researchers discovered that LTP could also amplify pain in areas where injuries or inflammation occur. “We sometimes call this a ‘memory trace of pain’ because the painful insult may lead to subsequent hypersensitivity to painful stimuli, and it was clear that synaptic plasticity can play a role here,” says study co-author Jürgen Sandkühler, a neuroscientist also at the Medical University of Vienna. But current models of how LTP works could not explain why discomfort sometimes becomes widespread or experienced in areas a person has never felt it before, he adds. © 2016 Scientific American
Nancy Shute Erik Vance didn't go to a doctor until he was 18; he grew up in California in a family that practiced Christian Science. "For the first half of my life, I never questioned the power of God to heal me," Vance writes in his new book, Suggestible You: Placebos, False Memories, Hypnosis, and the Power of Your Astonishing Brain. As a young man, Vance left the faith behind, but as he became a science journalist he didn't stop thinking about how people's beliefs and expectations affect their health, whether it's with placebo pills, mystical practices or treatments like acupuncture. The answer, he found, is in our brains. Erik and I chatted about the book while attending a recent meeting of the National Association of Science Writers. Here are highlights of our conversation, edited for length and clarity. You point out that even though most of us didn't grow up Christian Scientist, we often use belief to manage our health. I've learned from writing this book that there are a lot of people around the world who really rely on expectation and placebos. And I grew up in the most extreme possible group, but it's not that different from seeing a homeopath. You're using faith to manage your body; what a psychologist would call expectation. Having had that experience really prepared me to ask some of these questions. How would your mom take care of you when you were sick? As a kid we might have 7UP with orange juice; we might go that far because it made you feel better. But the treatment was to call a practitioner, to call a healer. © 2016 npr
Keyword: Pain & Touch
Link ID: 22847 - Posted: 11.09.2016
By Simon Oxenham Isy Suttie has felt “head squeezing” since she was young. The comedian, best known for playing Dobbie in the BBC sitcom Peep Show, is one of many people who experience autonomous sensory meridian response (ASMR) – a tingly feeling often elicited by certain videos or particular mundane interactions. Growing up, Suttie says she had always assumed everyone felt it too. Not everyone feels it, but Suttie is by no means alone. On Reddit, a community of more than 100,000 members share videos designed to elicit the pleasurable sensation. The videos, often described as “whisper porn”, typically consist of people role-playing routine tasks, whispering softly into a microphone or making noises by crinkling objects such as crisp packets. The most popular ASMR YouTuber, “Gentle Whispering”, has over 250 million views. To most of us, the videos might seem strange or boring, but the clips frequently garner hundreds of thousands of views. These videos often mimic real-life situations that provoke ASMR in susceptible people. Suttie says her strongest real-world triggers occur during innocuous interactions with strangers, like talking about the weather – “it’s almost as if the more superficial the subject the better,” Suttie says. She feels the sensation particularly strongly when someone brushes past her. For Suttie, the feelings are so powerful that she often feels floored by them, and they even overcome pain and emotional distress. During a trip to the dentist, she still experiences the pleasurable tingles when the assistant brushes past her, she says. © Copyright Reed Business Information Ltd.
By LISA SANDERS, M.D. Yesterday we challenged Well readers to take on the case of a 63-year-old artist who, over the course of several months, developed excruciating headaches, along with changes in his personality, his thinking, even in the way he painted. We provided you with some of the doctor’s notes and medical imaging results that led the doctor who finally made the diagnosis in the right direction. After an extensive evaluation, that doctor asked a single question that led him to make the diagnosis. We asked Well readers to figure out the question the doctor asked and the diagnosis it suggested. It must have been a tough case — or else you were all too worried about the coming election to rise to the challenge — because we got just over 200 responses, fewer than usual. Of those, only six of you figured out the right diagnosis, and only three of you got the question right as well. Despite that, I was very impressed by the thinking of even those who didn’t come up with the right diagnosis. Many of you thought about environmental factors like his recent retirement and his exposure to possible toxins from his painting, and that kind of thinking was, in my opinion, the very essence of thinking like a doctor. Strong work, all of you. The question the doctor asked that led him to the correct diagnosis was: Can you hear your heartbeat in your ears? The patient could. And that suggested the diagnosis: A dural-arteriovenous fistula, or DAVF © 2016 The New York Times Company
Keyword: Pain & Touch
Link ID: 22839 - Posted: 11.07.2016
By Kelly Servick Mark Hutchinson could read the anguish on the participants’ faces in seconds. As a graduate student at the University of Adelaide in Australia in the late 1990s, he helped with studies in which people taking methadone to treat opioid addiction tested their pain tolerance by dunking a forearm in ice water. Healthy controls typically managed to stand the cold for roughly a minute. Hutchinson himself, “the young, cocky, Aussie bloke chucking my arm in the water,” lasted more than 2 minutes. But the methadone patients averaged only about 15 seconds. “These aren’t wimps. These people are injecting all sorts of crazy crap into their arms. … But they were finding this excruciating,” Hutchinson says. “It just fascinated me.” The participants were taking enormous doses of narcotics. How could they experience such exaggerated pain? The experiment was Hutchinson’s first encounter with a perplexing phenomenon called opioid-induced hyperalgesia (OIH). At high doses, opioid painkillers actually seem to amplify pain by changing signaling in the central nervous system, making the body generally more sensitive to painful stimuli. “Just imagine if all the diabetic medications, instead of decreasing blood sugar, increased blood sugar,” says Jianren Mao, a physician and pain researcher at Massachusetts General Hospital in Boston who has studied hyperalgesia in rodents and people for more than 20 years. © 2016 American Association for the Advancement of Science
Keyword: Pain & Touch
Link ID: 22829 - Posted: 11.04.2016
A snake with the largest venom glands in the world could hold the answer to pain relief, scientists have found. Dubbed the "killer of killers", the long-glanded blue coral snake is known to prey on the likes of king cobras. The venom of the two-metre-long snake native to South East Asia acts "almost immediately" and causes prey to spasm. New research published in the journal Toxin found it targets receptors which are critical to pain in humans and could be used as a method of treatment. "Most snakes have a slow-acting venom that works like a powerful sedative. You get sleepy, slow, before you die," said Dr Bryan Fry of the University of Queensland who is one of a team of researchers working on a study into the effect of the snake's venom. "This snake's venom however, works almost immediately because it usually preys on very dangerous animals that need to be quickly killed before they can retaliate. It's the killer of killers." Turning into medicine? Cone snails and scorpions are some of a handful of invertebrates whose venom has been studied for its medical use. However, as a vertebrate, the snake is evolutionarily closer to humans, and so a medicine developed from its venom could potentially be more effective, says Dr Fry. "The venom targets our sodium channels, which are central to our transmission of pain. We could potentially turn this into something that could help relieve pain, and which might work better on us." The snake's venom glands extend to up to one-quarter of its body length. "It's got freaky venom glands, the longest of any in the world, but it's so beautiful. It's easily my favourite species of snake," said Dr Fry. © 2016 BBC.
By CATHERINE SAINT LOUIS Neither of the two drugs used most frequently to prevent migraines in children is more effective than a sugar pill, according to a study published on Thursday in The New England Journal of Medicine. Researchers stopped the large trial early, saying the evidence was clear even though the drugs — the antidepressant amitriptyline and the epilepsy drug topiramate — had been shown to prevent migraines in adults. “The medication didn’t perform as well as we thought it would, and the placebo performed better than you would think,” said Scott Powers, the lead author of the study and a director of the Headache Center at Cincinnati Children’s Hospital Medical Center. A migraine is a neurological illness characterized by pulsating headache pain, sometimes accompanied by nausea, vomiting and sensitivity to light and noise. It’s a common childhood condition. Up to 11 percent of 7- to 11-year-olds and 23 percent of 15-year-olds have migraines. At 31 sites nationwide, 328 migraine sufferers aged 8 to 17 were randomly assigned to take amitriptyline, topiramate or a placebo pill for 24 weeks. Patients with episodic migraines (fewer than 15 headache days a month) and chronic migraines (15 or more headache days a month) were included. The aim was to figure out which drug was more effective at reducing the number of headache days, and to gauge which one helped children to stop missing school or social activities. © 2016 The New York Times Company
Keyword: Pain & Touch
Link ID: 22801 - Posted: 10.28.2016
Katherine Hobson Placebos can't cure diseases, but research suggests that they seem to bring some people relief from subjective symptoms, such as pain, nausea, anxiety and fatigue. But there's a reason your doctor isn't giving you a sugar pill and telling you it's a new wonder drug. The thinking has been that you need to actually believe that you're taking a real drug in order to see any benefits. And a doctor intentionally deceiving a patient is an ethical no-no. So placebos have pretty much been tossed in the "garbage pail" of clinical practice, says Ted Kaptchuk, director of the Program for Placebo Studies and the Therapeutic Encounter at Beth Israel Deaconess Medical Center. In an attempt to make them more useful, he has been studying whether people might see a benefit from a placebo even if they knew it was a placebo, with no active ingredients. An earlier study found that so-called "open-label" or "honest" placebos improved symptoms among people with irritable bowel syndrome. And Kaptchuk and his colleagues found the same effect among people with garden-variety lower back pain, the most common kind of pain reported by American adults. The study included 83 people in Portugal, all of whom had back pain that wasn't caused by cancer, fractures, infections or other serious conditions. All the participants were told that the placebo was an inactive substance containing no medication. They were told that the body can automatically respond to placebos, that a positive attitude can help but isn't necessary and that it was important to take the pills twice a day for the full three weeks. © 2016 npr
Keyword: Pain & Touch
Link ID: 22800 - Posted: 10.28.2016